Picture of Cellebrite DI logo

CLBT — Cellebrite DI News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousMid CapHigh Flyer

Cellebrite DI Ltd reports results for the quarter ended in June - Earnings Summary

* Cellebrite DI Ltd  CLBT.OQ  reported quarterly adjusted
earnings
of 10 cents​​ per share for the quarter ended in June, higher
than the same quarter last year, when the company reported EPS
of 5 cents.  The mean expectation of eight analysts for the
quarter was for earnings of 5 cents per share. Wall Street
expected results to range from -7 cents to 8 cents per share.
    * Revenue rose 24.8% to $95.71 million from a year ago;
analysts
expected $91.71 million. 
    * Cellebrite DI Ltd's reported EPS for the quarter was a
loss
of 12 cents​.
    * The company reported a quarterly loss of $23.81 million.
    * Cellebrite DI Ltd shares had risen by 16.7% this
quarter and
gained 61.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 22.8%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the software peer
group
is also "buy"

Wall Street's median 12-month price target for Cellebrite DI Ltd
is $14.50 
This summary was machine generated from LSEG data August 16 at
12:22 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      0.05           0.10           Beat
 Mar. 31 2024      0.06           0.08           Beat
 Dec. 31 2023      0.06           0.11           Beat
 Sep. 30 2023      0.05           0.10           Beat

Recent news on Cellebrite DI

See all news